We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Supreme Court Declines to Hear Pfizer’s Appeal in Celebrex Class Action
U.S. Supreme Court Declines to Hear Pfizer’s Appeal in Celebrex Class Action
May 3, 2010
The Supreme Court has declined to hear Pfizer’s appeal of a class action shareholder lawsuit accusing the company of misrepresenting the results
of a clinical study of its arthritis drug Celebrex.